4
Changes in Ownership
Prime Medicine, Inc. Filed Acc 0001894562-25-000043
Options or other derivatives
- Chief Executive Officer acquired 850,000 shares (grant or award)
- Chief Executive Officer returned 850,000 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Reine Allan Chief Executive Officer | 2025-08-01 | Returned to the company · Stock Option (right to buy) | −850,000 | 0 | D | ||
| Reine Allan Chief Executive Officer | 2025-08-01 | Grant or award · Stock Option (right to buy) | +850,000 | 850,000 | D | ||
Loading xslF345X05/wk-form4_1754440956.xml…